| Filed On | Filing |
|---|---|
| 14 Nov 2024 | SC 13G/A |
| 10 Jun 2024 | 15-12G |
| 03 Jun 2024 | SC 13G/A |
| 03 Jun 2024 |
Form 4: Viking Global Investors Lp, 10% owner and 7 others
Disposed of 7,150,826 shares (Other Transaction) ($215M) · Disposed of 1,038,765 Warrants (right to buy) (Other Transaction) ($31.2M) |
| 31 May 2024 |
Form 4: Inhibrx, Inc., 10% owner · Inhibrx Biosciences Inc
Disposed of 13,316,140 shares (Other Transaction) |
| 30 May 2024 |
Form 4: Vuori Kristiina Md, Director
Disposed of 60,000 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 |
Form 4: Manhard Kimberly, Director
Disposed of 65,759 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 |
Form 4: Lappe Mark, Director
Returned 3,045,654 shares to the issuer ($91.4M) · Disposed of 245,000 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 |
Form 4: Kayyem Jon Faiz, Director
Returned 3,274,301 shares to the issuer ($98.2M) · Disposed of 62,259 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 |
Form 4: Forsyth Douglas, Director
Returned 598,257 shares to the issuer ($17.9M) · Disposed of 62,259 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 |
Form 4: Eckelman Brendan P., Chief Scientific Officer
Sold 300,000 shares ($10.3M) · Returned 2,055,553 shares to the issuer ($61.7M) · Disposed of 33,334 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 |
Form 4: Deck Kelly, Chief Financial Officer
Disposed of 45,000 Stock Option (right to buy) (Disposition to Issuer) |
| 30 May 2024 | S-8 POS |
| 30 May 2024 | S-8 POS |
| 30 May 2024 | S-8 POS |
| 30 May 2024 | S-8 POS |
| 30 May 2024 | POSASR |
| 30 May 2024 | 8-K: Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more |
| 30 May 2024 | 25-NSE |
| 28 May 2024 | 144 |
Loading...
